Shanghai Rendu Biotechnology Co. Ltd. A (688193) — Free Cash Flow Generation Index

Latest as of December 2025: 0.68x

Shanghai Rendu Biotechnology Co. Ltd. A (688193) has a Free Cash Flow Generation Index of 0.68x as of December 2025. Free cash flow of CN¥15.33 Million represents 1% of operating cash flow (CN¥22.41 Million). Explore 688193 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.68x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥15.33 Million
CNY

Operating Cash Flow

CN¥22.41 Million
CNY

Capital Expenditures

CN¥7.07 Million
CNY

Shanghai Rendu Biotechnology Co. Ltd. A Free Cash Flow Generation Index (2019–2025)

Historical FCF Generation Index trend for Shanghai Rendu Biotechnology Co. Ltd. A across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does Shanghai Rendu Biotechnology Co. Ltd. A generate cash.

Annual Free Cash Flow Generation for Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)

Year-by-year Free Cash Flow Generation Index for Shanghai Rendu Biotechnology Co. Ltd. A. Check 688193 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2025 0.68x CN¥15.33 Million CN¥22.41 Million CN¥7.07 Million ▲ +20.4%
2024 0.57x CN¥13.86 Million CN¥24.39 Million CN¥10.52 Million ▲ +405.6%
2023 -0.19x CN¥-3.20 Million CN¥17.19 Million CN¥20.39 Million ▼ -136.2%
2021 0.51x CN¥27.97 Million CN¥54.44 Million CN¥26.48 Million ▼ -38.3%
2020 0.83x CN¥77.06 Million CN¥92.61 Million CN¥15.55 Million ▲ +127.6%
2019 -3.01x CN¥-41.16 Million CN¥13.67 Million CN¥54.83 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).